Growth inhibition and induction of apoptosis and differentiation of tanshinone IIA in human glioma cells

Journal of Neuro-Oncology

Volumn 82, Issue 1, 2007, Pages 11-21

  Wang, Jing ^a   Wang, Xiujie ^a   Jiang, Shu ^a   Yuan, Shulan ^a   Lin, Ping ^a   Zhang, Jie ^a   Lu, Yanrong ^a   Wang, Qi ^a   Xiong, Zhujuan ^a   Wu, Yaying ^a   Ren, Jingjing ^a   Yang, Hongliang ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Anticancer activity; Apoptosis; Differentiation induction; Glioma; Growth inhibition; Tanshinone IA

Indexed keywords

BROXURIDINE; CYTOCHROME P450 1A1; MESSENGER RNA; NESTIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; TANSHINONE; TANSHINONE 2A; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; ASTROCYTE; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; COLONY FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; GLIOMA CELL; HUMAN; HUMAN CELL; IC 50; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MORPHOLOGY; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BRAIN NEOPLASMS; CELL DIFFERENTIATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOMA; HUMANS; INTERMEDIATE FILAMENT PROTEINS; NERVE TISSUE PROTEINS; PHENANTHRENES; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; TUMOR CELLS, CULTURED;

EID: 33846965992     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-006-9242-x     Document Type: Article

References (47)

1. Gilbert MR (2006) Advances in the treatment of primary brain tumors: dawn of a new era? Curr Oncol Rep 8:45-49
2. Stupp R, Hegi ME, van den Bent MJ, Mason WP, Weller M, Mirimanoff RO, Cairncross JG (2006) Changing paradigms - an update on the multidisciplinary management of malignant glioma. Oncologist 11:165-180
3. Wick W, Naumann U, Weller M (2006) Transforming growth factor-beta: A molecular target for the future therapy of glioblastoma. Curr Pharm Des 12:341-349
4. Kawamata H, Tachibana M, Fujimori T, Imai Y (2006) Differentiation-inducing therapy for solid tumors. Curr Pharm Des 12:379-385
5. Cuevas P, Diaz-Gonzalez D, Dujovny M (2004) Differentiation-inducing activity of neomycin in cultured rat glioma cells. Neurol Res 26:401-403
6. Jiang H, Zhang L, Kuo J, Kuo K, Gautam SC, Groc L, Rodriguez AI, Koubi D, Hunter TJ, Corcoran GB, Seidman MD, Levine RA (2005) Resveratrol-induced apoptotic death in human U251 glioma cells. Mol Cancer Ther 4:554-561
7. Cao EH, Liu XQ, Wang JJ, Xu NF (1996) Effect of natural antioxidant tanshinone II-A on DNA damage by lipid peroxidation in liver cells. Free Radic Biol Med 20:801-806
8. Xia WJ, Yang M, Fok TF, Li K, Chan WY, Ng PC, Ng HK, Chik KW, Wang CC, Gu GJ, Woo KS, Fung KP (2005) Partial neuroprotective effect of pretreatment with tanshinone IIA on neonatal hypoxia-ischemia brain damage. Pediatr Res 58:784-790
9. Wang X, Yuan S, Huang R, Song Y (1996) An observation of the effect of tanshinone on cancer cell proliferation by Brdu and PCNA labeling. Hua Xi Yi Ke Da Xue Xue Bao 27:388-391
10. Tang Z, Tang Y, Fu L (2003) Growth inhibition and apoptosis induction in human hepatoma cells by tanshinone II A. J Huazhong Univ Sci Technol Med Sci 23:166-168
11. Tang ZZ, Tang Y, Fu LB (2003) Effect of tanshinone IIA on the growth behavior of human hepatoma cell line BEL-7402 in vitro and its mechanism. Di Yi Jun Yi Da Xue Xue Bao 23:595-597
12. Yuan SL, Wei YQ, Wang XJ, Xiao F, Li SF, Zhang J (2004) Growth inhibition and apoptosis induction of tanshinone II-A on human hepatocellular carcinoma cells. World J Gastroenterol 10:2024-2028
13. Wang X, Wei Y, Yuan S, Liu G, Lu Y, Zhang J, Wang W (2005) Potential anticancer activity of tanshinone IIA against human breast cancer. Int J Cancer 116:799-807
14. Sung HJ, Choi SM, Yoon Y, An KS (1999) Tanshinone IIA, an ingredient of Salvia miltiorrhiza BUNGE, induces apoptosis in human leukemia cell lines through the activation of caspase-3. Exp Mol Med 31:174-178
15. Yoon Y, Kim YO, Jeon WK, Park HJ, Sung HJ (1999) Tanshinone IIA isolated from Salvia miltiorrhiza BUNGE induced apoptosis in HL60 human premyelocytic leukemia cell line. J Ethnopharmacol 68:121-127
16. Liang Y, Yang Y, Yuan S, Liu T, Jia Y, Xu C, Niu T, Qin H, Qin P (2000) Terminal ifferentiation of human acute promyelocytic leukemia (APL) cells induced by Tanshinone IIA in primary culture. Hua Xi Yi Ke Da Xue Xue Bao 31:207-210
17. Wu Y, Yang Y, Meng W, Li Y, Jia Y, Liu T (2002) Study on the differentiation of K562 cell-line induced by Tanshinone II A. Hua Xi Yi Ke Da Xue Xue Bao 33:80-83
18. Wang ZY (2003) Ham-wasserman lecture: Treatment of acute leukemia by inducing differentiation and apoptosis. Hematology (Am Soc Hematol Education Program) 1:1-13
19. Liao HF, Shyu SY, Kuo YH, Yang YC, Chen YJ (2005) Compound 278E, structurally modified from tanshinone, induces monocytic differentiation and regulates proto-oncogene expression in human leukemic HL-60 cells. Anticancer Drugs 16:175-183
20. Selvakumaran M, Pisarcik DA, Bao R, Yeung AT, Hamilton TC (2003) Enhanced cisplatin cytotoxicity by disturbing the nucleotide excision repair pathway in ovarian cancer cell lines. Cancer Res 63:1311-1316
21. Thor AD, Liu S, Moore II DH, Edgerton SM (1999) Comparison of mitotic index, in vitro Bromodeoxyuridine labeling, and MIB-1 assays to quantitate proliferation in breast cancer. J Clin Oncol 17:470-477
22. Ribble D, Goldstein NB, David A, Norris DA, Shellman YG (2005) A simple technique for quantifying apoptosis in 96-well plates. BMC Biotechnol. 5:1-7
23. Li XN, Parikh S, Shu Q, Jung HL, Chow CW, Perlaky L, Leung HC, Su J, Blaney S, Lau CC (2004) Phenylbutyrate and phenylacetate induce differentiation and inhibit proliferation of human medulloblastoma cells. Clin Cancer Res 10:1150-1159
24. Liu Y, Wang X, Liu Y (2003) Protective effects of tanshinone IIA on injured primary cultured rat hepatocytes induced by CCl 4. Zhong Yao Cai 26:415-417
25. Liu Y, Chen H, Jiang Y (2004) Protective effect of tanshinone IIA on acute hepatic injury in mice. Zhong Yao Cai 24:588-589
26. Wu WL, Chang WL, Chen CF (1991) Cytotoxic activities of tanshinones against human carcinoma cell lines. Am J Chin Med 19:207-216
27. Milosevic J, Kanazir S, Medic-Mijacevic L, Pejanovic V, Stokic Z, Konjevic G, Rakic L, Ruzdijic S (2002) Sulfinosine-induced cell growth inhibition and apoptosis in human lung carcinomas in vitro. Invest New Drugs 20:229-240
28. Griesenbeck J, Oei SL, Mayer-Kuckuk P, Ziegler M, Buchlow G, Schweiger M (1997) Protein-protein interaction of the human poly(ADP-ribosyl)transferase depends on the functional state of the enzyme. Biochemistry 36:7297-7304
29. Lockett KL, Hall MC, Xu J, Zheng SL, Berwick M, Chuang SC, Clark PE, Cramer SD, Lohman K, Hu JJ (2004) The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function. Cancer Res 64:6344-6348
30. Koh DW, Dawson TM, Dawson VL (2005) Mediation of cell death by poly(ADP-ribose) polymerase-1. Pharmacol Res 52:5-14
31. Hatip-Al-Khatib I, Iwasaki K, Chung EH, Egashiea N, Mishima K, Fujiwara M (2004) Inhibition of poly (ADP-ribose) polymerase and caspase-3, but not caspase-1, prevents apoptosis and improves spatial memory of rats with twice-repeated cerebral ischemia. Life Sci 75:1967-1978
32. Takamura-Enya T, Watanabe M, Totsuka Y, Kanazawa T, Matsushima-Hibiya Y, Koyama K, Sugimura T, Wakabayashi K (2001) Mono(ADP-ribosyl)ation of 2′-deoxyguanosine residue in DNA by an apoptosis-inducing protein, pierisin-1, from cabbage butterfly. Proc Natl Acad Sci USA 98:12414-12419
33. Loaiza-Perez AI, Kenney S, Boswell J, Hollingshead M, Alley MC, Hose C, Ciolino HP, Yeh GC, Trepel JB, Vistica DT, Sausville EA (2004) Aryl hydrocarbon receptor activation of an antitumor aminoflavone: Basis of selective toxicity for MCF-7 breast tumor cells. Mol Cancer Ther 3:715-725
34. Liu J, Wang Q, Wu DC, Wang XW, Sun Y, Chen XY, Zhang KL, Li H (2004) Differential regulation of CYP1A1 and CYP1B1 expression in resveratrol-treated human medulloblastoma cells. Neurosci Lett 363:257-261
35. Loaiza-Perez AI, Kenney S, Boswell J, Hollingshead M, Hose C, Linehan WM, Worrell R, Rubinstein L, Sausville EA, Vistica DT (2004) Sensitivity of renal cell carcinoma to aminoflavone: Role of CYP1A1. J Urol 171:1688-1697
36. Li XN, Du ZW, Huang Q, Wu JQ (1997) Growth-inhibitory and differentiation-inducing activity of dimethylformamide incultured human malignant glioma cells. Neurosurgery 40:1250-1259
37. Rabon AS, Stern R, Tralka TS, Costa J, Wilczek J (1997) HMBA induces morphological changes and increased synthesis of procollagen in cell line from glioblastoma multiform. Proc Natl Acad Sci USA 74:5060-5064
38. Ebert PS, Salcman M (1994) Differentiation therapy is potentiated by chemotherapy and hyperthermia in human and canine brain tumor cells in vitro. Neurosurgery 34:657-664
39. Helseth E, Unsgaard G, Dalen A, Vik A (1988) Effects of type beta transforming growth factor in combination with retinoic acid or tumor necrosis factor on proliferation of a human glioblastoma cell line and clonogenic cells from freshly resected human brain tumors. Cancer Immunol Immunother 26:273-279
40. Rutka JT, DeArmond SJ, Giblin JR, McCulloch JR, Wilson CB, Rosenblum ML (1988) Effect of retinoids on the proliferation, morphology and expression of GFAP of an anaplastic astrocytoma cell line. Int J Cancer 42:419-427
41. Schmidt F, Groscurth P, Dichgans J, Weller M (2000) Human malignant glioma cell lines are refractory to retinoic acid-mediated differentiation and sensitization to apoptosis. Cell Physiol Biochem 10:159-168
42. Rutka JT, Giblin JR, Apodaca G, DeArmond SJ, Stern R, Rosenblum ML (1987) Inhibition of growth and induction of differentiation in a malignant human glioma cell line by normal leptomeningeal extracellular matrix proteins. Cancer Res 47:3515-3522
43. Rutka JT, Hubbard SL, Fukuyama K, Matsuzawa K, Dirks PB, Becker LE (1994) Effects of antisense glial fibrillary acidic protein complementary DNA on the growth, invasion and adhesion of human astrocytoma cells. Cancer Res 54:3267-3272
44. Kaluza J, Adamek D (1990) Expression of GFAP (glial fibrillary acidic protein) antigenicity and differentiation of glioma tumor cells of astrocytic origin. Folia Histochem Cytobiol 28:155-159
45. Sugawara K, Kurihara H, Negishi M, Saito N, Nakazato Y, Sasaki T, Takeuchi T (2002) Nestin as a marker for proliferative endothelium in gliomas. Lab Invest 82:345-351
46. Dahlstrand J, Collins VP, Lendahl U (1992) Expression of the class VI intermediate filament nestin in human central nervous system tumors. Cancer Res 52:5334-5341
47. Zhou R, Skalli O (2000) TGF-alpha differentially regulates GFAP, vimentin, and nestin gene expression in U-373 MG glioblastoma cells: correlation with cell shape and motility. Exp Cell Res 254:269-278